U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5649156491A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand EczemaTerminatedNo Results AvailableEczema|Hand Eczema|Atopic DermatitisOther: CLn BodyWash|Other: Cetaphil Daily Facial Cleanserhttps://ClinicalTrials.gov/show/NCT01826630
5649256492Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy OutcomeCompletedNo Results AvailableProstate Cancer|Prostatitis|Benign Prostatic Hyperplasiahttps://ClinicalTrials.gov/show/NCT01826617
5649356493Self-Retaining Retractor in Obese Patients Undergoing Cesarean SectionCompletedNo Results AvailablePregnancy|ObeseDevice: Alexis O C-Section Retractor|Other: Control- Conventional hand-held retractorshttps://ClinicalTrials.gov/show/NCT01826604
5649456494Diet X Genotype StudyRecruitingNo Results AvailableObesity|Insulin ResistanceBehavioral: Low-Carbohydrate Diet|Behavioral: Low-Fat Diet|Behavioral: Mobile Apphttps://ClinicalTrials.gov/show/NCT01826591
5649556495Single Port Myomectomy Versus Conventional MyomectomyNot yet recruitingNo Results AvailableCosmetic OutcomesProcedure: using only one port for laparoscopic surgeryhttps://ClinicalTrials.gov/show/NCT01826578
5649656496Comparison of Two Insertion Technique of I-gelNot yet recruitingNo Results AvailableProstate Cancer|Prostate Tumor|Bladder Cancer|Bladder TumorProcedure: Rotational techniquehttps://ClinicalTrials.gov/show/NCT01826565
5649756497Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity StentRecruitingNo Results AvailableCoronary Artery Disease|Coronary Heart Disease|Stable Angina|Unstable Angina|ST-segment Elevation Myocardial Infarction|Non-ST-segment Elevation Myocardial InfarctionDevice: Osiro Hybrid Drug-Eluting Stent|Device: Resolute Integrityhttps://ClinicalTrials.gov/show/NCT01826552
5649856498A Comparison of Dorsal Branch of the Digital Nerve Versus Dorsal Digital Nerve for Finger Pulp ReconstructionCompletedNo Results AvailableSoft Tissue Defect of the FingerProcedure: flap includes a donor nervehttps://ClinicalTrials.gov/show/NCT01826539
5649956499Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%RecruitingNo Results AvailableCatheter Related Blood Stream InfectionsDevice: TauroSept®https://ClinicalTrials.gov/show/NCT01826526
5650056500AutoSet for Her Clinical Trial ProtocolCompletedNo Results AvailableObstructive Sleep ApneaDevice: Modified AutoSet algorithmhttps://ClinicalTrials.gov/show/NCT01826513
5650156501VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological SituationsRecruitingNo Results AvailableIVF|EndometriosisOther: blood testhttps://ClinicalTrials.gov/show/NCT01826500
5650256502Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular DystrophyActive, not recruitingNo Results AvailableMuscular Dystrophy, Duchenne|Muscular Dystrophies|Muscular Disorders, Atrophic|Muscular Diseases|Musculoskeletal Diseases|Neuromuscular Diseases|Nervous System Diseases|Genetic Diseases, X-Linked|Genetic Diseases, InbornDrug: Ataluren|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01826487
5650356503Phase IIb Study of PRO045 in Subjects With Duchenne Muscular DystrophyActive, not recruitingNo Results AvailableDuchenne Muscular DystrophyDrug: PRO045, 0.15 mg/kg/week|Drug: PRO045, 1.0 mg/kg/week|Drug: PRO045, 3.0 mg/kg/week|Drug: PRO045, 6.0 mg/kg/week|Drug: PRO045, 9.0 mg/kg/week|Drug: PRO045, selected dosehttps://ClinicalTrials.gov/show/NCT01826474
5650456504An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNo Results AvailableAtopic DermatitisDrug: PDI-192|Drug: Vehiclehttps://ClinicalTrials.gov/show/NCT01826461
5650556505A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF MelanomaTerminatedNo Results AvailableV600-mutated BRAF Unresectable Melanoma|V600-mutated BRAF Metastatic Melanoma|Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorDrug: PLX3397|Drug: vemurafenibhttps://ClinicalTrials.gov/show/NCT01826448
5650656506Improving Medication Adherence in Hypertensive PatientsWithdrawnNo Results AvailableHypertensionBehavioral: Electronic Interventionhttps://ClinicalTrials.gov/show/NCT01826435
5650756507Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB PatientsEnrolling by invitationNo Results AvailableMuscular Dystrophy, DuchenneDietary Supplement: EPA and DHA|Dietary Supplement: Placebo Comparator: Sunflower oilhttps://ClinicalTrials.gov/show/NCT01826422
5650856508Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 DiabetesCompletedNo Results AvailableImpaired Glucose or Type 2 DiabetesDietary Supplement: Fermented Red Ginseng|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01826409
5650956509Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon CancerRecruitingNo Results AvailableColonic NeoplasmsDrug: Irinotecanhttps://ClinicalTrials.gov/show/NCT01826396
5651056510Improving Parental Soothing by VideoCompletedNo Results AvailableAcute PainBehavioral: Active-Video|Behavioral: Placebo Videohttps://ClinicalTrials.gov/show/NCT01826383
5651156511Linagliptin Among Filipino Patients With Type 2 Diabetes MellitusTerminatedHas ResultsDiabetes Mellitus, Type 2Drug: Linagliptinhttps://ClinicalTrials.gov/show/NCT01826370
5651256512Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive AgeRecruitingNo Results AvailableMetabolic Cardiovascular Syndromehttps://ClinicalTrials.gov/show/NCT01826357
5651356513The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance StudyActive, not recruitingNo Results AvailableAbdominal Aortic Aneurysms (AAA)https://ClinicalTrials.gov/show/NCT01826344
5651456514Incentives for Participation Versus OutcomesActive, not recruitingNo Results AvailableSmokingBehavioral: Incentives for Participation|Behavioral: Incentives for Cessationhttps://ClinicalTrials.gov/show/NCT01826331
5651556515Stress Coping Strategy on Perceived Stress Levels and Performance During a Simulated Cardiopulmonary ResuscitationCompletedNo Results AvailableCardiopulmonary ResuscitationsBehavioral: Stress copinghttps://ClinicalTrials.gov/show/NCT01826318
5651656516Independent Exercise Compared With Formal Rehabilitation Following Primary Total Knee ReplacementRecruitingNo Results AvailableRecovery Following Primary Total Knee ArthroplastyProcedure: Formal Rehabilitation Therapy|Procedure: Independent Exercise Cohorthttps://ClinicalTrials.gov/show/NCT01826305
5651756517The Association Between Anesthetic and Surgical Practices and Patient Length of Stay in the Post Anesthesia Care UnitActive, not recruitingNo Results AvailablePost Anesthesia Care Unit Length of Stayhttps://ClinicalTrials.gov/show/NCT01826292
5651856518Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass SurgeryActive, not recruitingNo Results AvailableObesityDietary Supplement: Resveratrol|Other: Placebohttps://ClinicalTrials.gov/show/NCT01826279
5651956519Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of EdoxabanCompletedNo Results AvailableAnticoagulant Reversal.|Reversal of Edoxaban Induced Anticoagulation.Drug: PER977, Placebohttps://ClinicalTrials.gov/show/NCT01826266
5652056520Observational Study of Oxygen Delivery During a Fractional Fluid ExpansionCompletedNo Results AvailableHypovolemia|Impaired Oxygen Delivery|Cardiac Output, LowDrug: hydroxyethylstarch 130/0.4https://ClinicalTrials.gov/show/NCT01826253

* Görseller ve İçerik tekif hakkına sahip olabilir